openPR Logo
Press release

E3 Ubiquitin Protein Ligase XIAP Market Size & Growth Analysis Report, 2021-2027

02-24-2022 10:37 AM CET | Health & Medicine

Press release from: Orion Market Research

The global E3 ubiquitin protein ligase XIAP market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Ubiquitin ligase is also called as E3 ubiquitin ligase. It is a protein that staffs an E2 ubiquitin-conjugating enzyme that has been loaded with ubiquitin and recognizes a protein substrate while assisting or directly catalyzing the transfer of ubiquitin from the E2 to the protein substrate. The major factor for the growth of the market is the increasing prevalence of cancer across the globe.

To Request a Sample of our Report on E3 Ubiquitin Protein Ligase XIAP Market: https://www.omrglobal.com/request-sample/e3-ubiquitin-protein-ligase-xiap-market

According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. In men, prostate, lung, and colorectal cancers will account for an estimated 43% of all cancers diagnosed while for women, the three most common cancers are breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in women in 2020. Furthermore, there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. Hence, the rising prevalence of cancer is driving the growth of the market as E3 ubiquitin protein ligase XIAP plays a crucial role in protein function and regulation.

Some major key players in the market include Novartis International AG, Bristol-Myers Squibb Company, and Takeda Pharmaceutical Company Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. In addition, funding opportunity has been witnessed, which in turn, is expected to drive the market growth during the forecast period. For instance, in June 2021, Stablix Therapeutics announced a $63 million Series A financing which was led by founding investor Versant Ventures with NEA, Cormorant, Euclidean Capital and Alexandria Real Estate Equities. Stablix is a biotechnology company that pioneers in the field of Targeted Protein Stabilization (TPS).

Market Coverage

• The market number available for - 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

Segment Covered-

· By Type

· By Application

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- Novartis International AG, Bristol-Myers Squibb Company, and Takeda Pharmaceutical Company Ltd., among others.

(Get 15% Discount on Buying this Report)

A full Report of E3 Ubiquitin Protein Ligase XIAP Market is Available @ https://www.omrglobal.com/industry-reports/e3-ubiquitin-protein-ligase-xiap-market

Global E3 Ubiquitin Protein Ligase XIAP Market Report by Segment

By Type

• ASTX-660

• FL-118

• AD-O53.2

• LCL-161

• SM-1200

• Others

By Application

• Solid Tumor

• Fallopian Tube Cancer

• Lung Cancer

• Peritoneal Cancer

• Others

Global E3 Ubiquitin Protein Ligase XIAP Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release E3 Ubiquitin Protein Ligase XIAP Market Size & Growth Analysis Report, 2021-2027 here

News-ID: 2562452 • Views:

More Releases from Orion Market Research

Polyolefin Pipe Market Will Exhibit an Impressive Expansion by 2024-2031 | AGRU, Arya Sasol Polymer Co., Asahi Kasei Group
Polyolefin Pipe Market Will Exhibit an Impressive Expansion by 2024-2031 | AGRU, …
The global polyolefin pipe market is anticipated to grow at a considerable CAGR of 5.2% during the forecast period. There are several growth opportunities present in the polyolefin pipe market, one such opportunity is the growing need for PO pipes in communication and cooking gas supplies in modern urbanizing environments. As the world is pushing towards development and urbanizing rapidly, developing countries are heavily investing in large-scale expansion of fiber optic networks.
Pipe Coatings Market Update Report 2024| Industry Trends, Demand, Leading Companies and Segmentation till 2031/ 3M Co., W. Chesterton Co., Arkema SA
Pipe Coatings Market Update Report 2024| Industry Trends, Demand, Leading Compan …
This Pipe Coatings Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Pipe Coatings Market study report. All this
Meat Snacks Market Size, Share, Trends, Demand, Segments, Leading Companies and Forecast till 2031 / Associated British Food Plc, Beyond Meat, Inc., Big Chief Meat Snacks, Inc.
Meat Snacks Market Size, Share, Trends, Demand, Segments, Leading Companies and …
Meat Snacks Market is anticipated to showcase a moderate CAGR of 5.6% during the forecast period. The key factors that drive the growth of the meat snacks market include the increasing focus of meat snack manufacturers towards innovations. The key companies across the globe are highly inclined towards expanding their production capabilities via the expansion of their production facilities. For instance, In August 2020, Turasky Meats, a Springfield, Ill.-based meat
Meal Kit Delivery Services Market Increasing Demand, Growth Analysis and Future Outlook by 2031/ Blue Apron, LLC, Freshly Inc., Fresh Prep Foods Inc., Grocery Delivery E-Services USA, INC.
Meal Kit Delivery Services Market Increasing Demand, Growth Analysis and Future …
The global meal kit delivery services market is anticipated to grow at a considerable CAGR of 8.1% during the forecast period. With the shift in the work environment over the recent year from office to home, the market is observing a sudden rise in the adoption of B2B platforms for meal kit delivery services by major market players. Meal kit delivery service providers are inclining toward giving employers and companies digital benefits

All 5 Releases


More Releases for XIAP

Direct Carrier Billing Market Projected to Grow at a Steady Pace During 2021-202 …
This Direct Carrier Billing market report also comprises of significant info on COVID-19 and its impact on the economy. The Pandemic has not only becoming the global epidemic, and it has also had an economic impact on the world. Reduced productivity, casualties, business failure, trade instability, and the annihilation of the tourist economy have all had considerable consequences around the world. COVID-19 could be a " waking up " call
Latest Trends in E3 Ubiquitin Protein Ligase XIAP Market 2018: QY Research
In the recently published report, QY Research has provided a unique insight into the global E3 Ubiquitin Protein Ligase XIAP market for the forecasted period of 7-years (2018-2025). The report has covered the significant aspects that are contributing the growth of the global E3 Ubiquitin Protein Ligase XIAP market. The primary objective of this report is to highlight the various key market dynamics such as drivers, trends, and restraints that are impacting the global E3 Ubiquitin
E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or …
ReportsWorldwide has announced the addition of a new report title E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like
E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or …
E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - E3 Ubiquitin-Protein Ligase X-linked inhibitor of apoptosis protein (XIAP) also known as inhibitor of apoptosis protein 3 (IAP3) and baculoviral IAP repeat-containing protein 4 (BIRC4) is a protein that stops apoptotic cell death. It modulates inflammatory
E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or …
"E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Directs, E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein
New Study on Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies D …
Researchmoz added Most up-to-date research on "Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation" to its huge collection of research reports. Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is the most common and aggressive human brain tumor, accounting for 15.4% of all primary brain tumors and 60-75% of all astrocytomas. It has a peak incidence between 55 and 84 years of age,